SunRegen Healthcare AG is a biopharmaceutical company based in Basel Area. It is focusing on innovative treatments for patients with ophthalmic diseases. The first drug candidate is in development for neurodegenerative eye disease and in evaluation for other neurodegenerative diseases. SunRegen team is composed of passionate, innovative and persistent experts who have track records of drug development, clinical research, commercialization and managementexperiences in big pharma.
View Top Employees from SunRegen Healthcare AG| Website | http://www.sunregen.ch |
| Revenue | $4 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2017 |
| Address | Gewerbestrasse 24, Allschwil, Basel-Landschaft 4123, CH |
| Phone | +41 76 480 56 28 |
| Technologies | |
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Healthcare, Science and Engineering, Drug Manufacturing & Research |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular SunRegen Healthcare AG employee's phone or email?
SunRegen Healthcare AG Questions
The SunRegen Healthcare AG annual revenue was $4 million in 2024.
Mark Freedman is the Chief Executive Officer and Member of the Board of SunRegen Healthcare AG.
3 people are employed at SunRegen Healthcare AG.
SunRegen Healthcare AG is based in Allschwil, Basel-Landschaft.
The NAICS codes for SunRegen Healthcare AG are [3254, 325, 32, 32541].
The SIC codes for SunRegen Healthcare AG are [28, 283].
Top SunRegen Healthcare AG Employees
-
View
Dong Yuhong
Director, Chief Scientific Officer, Founder at SunRegen Healthcare AG
Basel, Basel-City, Switzerland2 -
1
-
ViewMark Freedman
Chief Executive Officer and Member of the Board at SunRegen Healthcare AG
Basel, Basel-City, Switzerland2
Related Companies
